Biosafety concerns at U of Wisconsin Ebola lab

A University of Wisconsin researcher working with the Ebola virus operated his lab under lower biosafety standards than are required for working with the deadly pathogen, according to the Sunshine Project, an Austin-based biosafety watchdog group. A linkurl:press release;http://www.sunshine-project.org/publications/pr/pr190907.html posted on the group's Web site and an linkurl:AP report;http://www.madison.com/wsj/home/local//index.php?ntid=246861 filed late last night state that the lab, headed

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A University of Wisconsin researcher working with the Ebola virus operated his lab under lower biosafety standards than are required for working with the deadly pathogen, according to the Sunshine Project, an Austin-based biosafety watchdog group. A linkurl:press release;http://www.sunshine-project.org/publications/pr/pr190907.html posted on the group's Web site and an linkurl:AP report;http://www.madison.com/wsj/home/local//index.php?ntid=246861 filed late last night state that the lab, headed by virologist Yoshi Kawaoka, was working with cDNAs of the virus, which don't replicate and thus cant cause infection. Although NIH regulations require all work with Ebola to be done under Biosafety Level 4 (BSL4) conditions, the group was working in a BSL3 lab. The level of safety they upheld had been approved by the institution, and the work was funded by the NIH. The NIH didn't realize the oversight until Kawaoka began petitioning UW to allow the work to proceed under BSL2 conditions, and the university turned to the agency for guidance. The research was suspended last year. The Sunshine Project is looking into a possibly similar incident at Tulane University in New Orleans, the release says. On Monday, the group linkurl:announced;http://www.the-scientist.com/blog/display/53600/ it had uncovered a series of biosafety breaches at three University of Texas schools, some of which were never reported to the CDC.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo